SCHEMBL9130804

SCHEMBL9130804

CCCSCC1=CCN(C)CC1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.43
QDPR P09417 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9129646 0.86 QDPR (0.36) SIGMAR1QDPR
SCHEMBL9130250 0.78 QDPR (0.38) SIGMAR1QDPR
SCHEMBL9644027 0.76 QDPR (0.39) SIGMAR1QDPR
SCHEMBL7607024 0.75
SCHEMBL13599361 0.73 QDPR (0.37) SIGMAR1QDPR
SCHEMBL9127424 0.71 QDPR (0.36) SIGMAR1QDPR
SCHEMBL10752307 0.71 QDPR (0.36) SIGMAR1QDPR
SCHEMBL4700734 0.70
SCHEMBL6953079 0.70
SCHEMBL15370330 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5422353-A Alzheimer*s disease, glaucoma treatment BOEHRINGER INGELHEIM KG (DE) 1995-06-06 US disclosed
EP-0325263-B1 TETRAHYDROPYRIDINE DERIVATIVES BOEHRINGER INGELHEIM KG (DE) 1992-09-23 EP disclosed
EP-0325263-A1 Tetrahydropyridine derivatives BOEHRINGER INGELHEIM KG (DE) 1989-07-26 EP disclosed